Royce & Associates’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.3K | Sell |
17,285
-1,440
| -8% | -$4.94K | ﹤0.01% | 774 |
|
|
2025
Q1 | $55.4K | Hold |
18,725
| – | – | ﹤0.01% | 786 |
|
|
2024
Q4 | $57.1K | Sell |
18,725
-1,440
| -7% | -$4.39K | ﹤0.01% | 823 |
|
|
2024
Q3 | $51.4K | Buy |
20,165
+8,427
| +72% | +$21.5K | ﹤0.01% | 858 |
|
|
2024
Q2 | $38.3K | Hold |
11,738
| – | – | ﹤0.01% | 868 |
|
|
2024
Q1 | $62.2K | Buy |
+11,738
| New | +$62.2K | ﹤0.01% | 868 |
|
|
2020
Q3 | – | Sell |
-1,890
| Closed | -$20K | – | 1127 |
|
|
2020
Q2 | $20K | Buy |
1,890
+42
| +2% | +$444 | ﹤0.01% | 1116 |
|
|
2020
Q1 | $16K | Buy |
+1,848
| New | +$16K | ﹤0.01% | 1108 |
|
|
2019
Q4 | – | Sell |
-1,749
| Closed | -$19K | – | 1164 |
|
|
2019
Q3 | $19K | Buy |
+1,749
| New | +$19K | ﹤0.01% | 1113 |
|